All Articles

Private equity firm Access Holdings invests in Reliable Towing, aiming to modernize the fragmented roadside assistance market with data, tech, and scale.

Valvoline's stellar Q3 results reveal a masterclass in corporate strategy, turning rising costs into record profits. But is this a sustainable model?

Sprott’s AUM fell 15% on a precious metals slump, yet key metrics soared year-over-year. A critical look at a firm weathering volatility via diversification.

Shake Shack's Q2 results show impressive revenue growth and customer traffic, yet profits are shrinking. A deep dive reveals a company grappling with the high cost of expansion and inflation.

Biotech firm Kindred Companion Sciences has used CRISPR to create two beagles free of the main allergen, offering hope to millions but raising complex ethical questions.

With a fresh $37M, WindBorne Systems is scaling its fleet of AI-guided balloons to create a new intelligence layer for our weather-dependent world.

Acacia Research's Q2 results show a massive revenue jump from a patent deal, but a $31M write-down reveals the risks in its diversified strategy.

CI Global Asset Management's special payout on its gold ETF is more than cash for investors; it's a signal of strength amid massive corporate transformation.

CDW's Q2 earnings beat expectations with a 10% sales jump, thanks to AI and cloud demand. But a dip in gross margins and restructuring costs spooked the market.

AI is no longer just a chatbot. Autonomous agents are now handling real work, creating massive security gaps. A new partnership aims to make them visible.

As J.M. Smucker prepares for a pivotal earnings call, a deeper look reveals a company balancing legacy brands with high-growth bets in a shifting market.

A quiet South Korean biotech is shaking up the drug delivery landscape. Alteogen's latest deal signals a major shift as Big Pharma races to make treatments better.

As ONE Nuclear nears its public debut via a SPAC merger, it pitches a hybrid energy solution for data centers. Can it navigate financial and regulatory risks?

With a fresh $50M, travel tech firm Faye is betting on AI to resolve claims before your vacation is over. But can technology truly automate peace of mind?

Gaming giant Bigben Interactive files for accelerated safeguard, tying its fate to subsidiary Nacon in a complex deal that promises survival but spells disaster for current investors.

EMP Metals completes its Project Aurora demo plant, a crucial test for Direct Lithium Extraction tech and a key move in Canada's strategy for a domestic EV supply chain.

Eton Pharmaceuticals' new deal for ASN-001 is more than a pipeline buy; it's a calculated maneuver to capture the entire infantile hemangioma treatment space.

With strong Q3 results and declining vacancy, Mainstreet Equity is shifting from defense to offense, betting big on Alberta's booming economy and tightening rental supply.

Carolinas AGC honored three construction legends whose careers shaped the region’s infrastructure. Their legacy offers a playbook for today's economic boom.

Nicotine giant BAT is marketing its Velo pouches as a cure for loneliness at music festivals. But is this genuine connection or a sophisticated new playbook for addiction?